Yang Ping plans to temporarily focus his energy on tumor treatment. After overcoming some key technologies in the K therapy, he will then shift to research in other fields.

Since Yang Ping's own research fund is currently strong, he does not need state-allocated funds. This can save substantial funds for the state, allowing these funds to be allocated to more other research projects.

Scientific and technological research should be decentralized to thrive, only when a hundred flowers bloom and everyone studies their own topics can rapid development occur. Innovation must be a multi-centered development.

Because the failure rate of original innovation is very high, only by conducting different research can there be a possibility of success. If everyone's research is similar, once it fails, there is no turning back.

Yang Ping attended the laboratory discussion in the afternoon. The meeting focused on the next steps in K therapy, whether to continue improving the effect and safety of K therapy or to shift towards finding more K factors.

Of course, this is just the focus. It doesn't mean that transferring the research focus to finding more K factors will abandon improving the effect and safety of the K therapy. It's merely about different manpower distribution, as the current laboratory team is not large enough. When one day, if the laboratory has over ten thousand people, then many topics can blossom simultaneously, but for now, we must focus on one core topic.

The laboratory, after several recruitments, now has more than a hundred people combined, and even with slightly over a hundred people seated in the meeting room, it seems quite sizable.

Everyone is quite excited, feeling very motivated. The success of the K therapy has greatly boosted their confidence. Tang Shun, as the secretary of the Medical Science Academy, was the first to speak, "This meeting is to discuss our next work focus. Everyone can speak freely, regardless of whether your ideas are mature. There are some things that need to be put on the table for discussion to determine right from wrong."

"The progress of K therapy from project initiation to now is evident to all. Although there were some minor setbacks in the entire research process, overall, it has been very smooth, with no deviation in the grand direction, let alone errors. In major subjects, this level of clarity in direction is extremely rare. For the next steps, I suggest that while continuing to improve the effect and safety of the K therapy, we also need to develop more K factors to expand the applicability range of K therapy. Currently, horizontally expanding the applicability range is more important than vertically improving the effect and safety, since the effect and safety of K therapy are already very good, and any further improvements can be made after the first, second, and third phase clinical trials expose some issues."

"I wonder what everyone thinks of this. We only have over a hundred people in total, with each laboratory having about fifty people. Currently, the team still has stem cell research ongoing, so we cannot divert more energy to other tasks. We must focus, and only focus."

Tang Shun shared his thoughts, believing that everyone's thinking aligned with his. Original innovation demands researchers be filled with passion, as this passion for science is the continuous driving force.

"I agree with Doctor Tang's opinion. For the treatment of osteosarcoma and a few other tumors, the current effect and safety of K therapy are already very good. We don't need to invest massive energy further. Post-clinical trials, we can modify and improve based on exposed issues. A team of a dozen people is entirely capable of handling this, allowing others to invest in searching for new K factors." Lu Xiaolu's thoughts were similar to Tang Shun's.

Yang Ping despises meetings and has never attended the various meetings at the hospital, big or small. Of course, he definitely attends case discussions. He participates in routine meetings like this one, but usually refrains from speaking until the end, usually playing the role of a finale.

Tang Shun and Lu Xiaolu know his habits, so they let him rest, even if it meant he was resting with his eyes closed. Everyone understands that when the professor is meditating with closed eyes, he is actually thinking.

Yang Ping leaned back against the chair, seemingly resting with his eyes closed, but he was actually thinking in the System Space. Even a brief moment in reality can be a long time in the System Space, so as long as no one disturbs him during a meeting, he can think for a long time and do many things inside.

"I believe there is no doubt about shifting the focus of our work, as everyone thinks the same. The key issue now is determining the timeline for the next research plan. Although no one can predict the future, this is scientific research, and it must have a strong sense of planning, even if the plan proves wrong in the end and needs to be overturned. We still need to conduct scientifically planned research," a doctor said.

Everyone agreed unanimously. Tang Shun and Lu Xiaolu looked at Yang Ping, who was meditating with closed eyes. His silence was a tacit agreement. If he had a different opinion, he would definitely open his eyes and speak up. Since Professor Yang didn't speak, they didn't want to disturb him.

In fact, hardly anyone opposed the views of Tang Shun and Lu Xiaolu because, after the breakthrough progress of the K therapy, everyone was eager to search for new K factors. They aimed to conduct in-depth research on K factors themselves to expand the applicability of K therapy.

If the mystery of the K factor itself can truly be unraveled, further improvement in the effect of K therapy will once again be possible. Relying on various patches and fixes has already made it very difficult to enhance the effect further, as it has reached a bottleneck period.

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.